Related Experiment Video

Updated: Jun 13, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Epidemiology of cardiorenal syndromes

Sean M Bagshaw, Dinna N Cruz

    Contributions to Nephrology
    |April 30, 2010
    PubMed

    Insights

    Cardiorenal syndrome (CRS) involves heart and kidney disease. Understanding the epidemiology of its subtypes is crucial for disease burden assessment and future research.

    Area of Science:

    • Cardiology
    • Nephrology
    • Epidemiology

    Background:

    • Cardiac and kidney diseases are prevalent and often occur together.
    • A consensus classification for cardiorenal syndrome (CRS) and its subtypes has been established.
    • The five CRS subtypes share pathophysiology but may differ in clinical presentation and outcomes.

    Purpose of the Study:

    • To summarize the epidemiology of cardiorenal syndrome (CRS) and its subtypes.
    • To highlight the importance of epidemiological understanding for disease burden assessment.
    • To identify knowledge gaps and inform future research and clinical trials.

    Main Methods:

    • This review synthesizes existing epidemiological data on CRS.
    • It examines the burden of disease, morbidity, mortality, and healthcare utilization across CRS subtypes.

    Main Results:

    • Epidemiological data is fundamental for understanding the impact of CRS subtypes.
    • Appreciating the epidemiology aids in identifying risk factors and outcomes.
    • This knowledge is essential for designing targeted interventions and trials.

    Conclusions:

    • A comprehensive understanding of CRS epidemiology is vital.
    • Further epidemiological investigations are needed to refine understanding and management.
    • Epidemiological insights guide the development of effective treatments for CRS.

    More Related Videos

    Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches06:51

    Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

    Published on: September 5, 2025

    Related Concept Videos

    Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

    Acute Kidney Injury IV: Diagnostic Studies and Prevention

    Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
    Acute Kidney Injury II: Pathophysiology01:29

    Acute Kidney Injury II: Pathophysiology

    Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    Acute Kidney Injury III: Clinical Manifestations01:29

    Acute Kidney Injury III: Clinical Manifestations

    Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
    Nephrotic Syndrome I : Introduction01:24

    Nephrotic Syndrome I : Introduction

    Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...